Related Experiment Video
Updated: Aug 13, 2026
11:43
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
Raman consensus estimation for metastatic tumor origin assessment: a proof-of-concept study in colorectal liver
Yusong Peng1, Jinglei Zhang2, Li Li2
1Department of Materials Science and Engineering, College of Engineering and Applied Sciences, Nanjing University Nanjing China.
RSC Advances
|August 12, 2026
Summary
This study introduces Raman consensus estimation, a new method to rapidly identify the origin of metastatic tumors using label-free spectroscopic fingerprints. This technique accurately determined the primary origin of colorectal liver metastases, offering a faster alternative for cancer diagnosis.
Area of Science:
- Biomedical Optics
- Spectroscopy
- Oncology
Background:
- Accurate determination of metastatic tumor origin is crucial for effective cancer treatment and prognosis.
- Current methods for assessing tumor origin face challenges including limited tissue, long turnaround times, and sampling bias.
- Cancers of unknown primary (CUP) present a significant diagnostic challenge.
Purpose of the Study:
- To develop and validate a novel, label-free framework for inferring the primary origin of metastatic tumors.
- To address limitations of current origin-assessment workflows, particularly in cases of cancers of unknown primary (CUP).
- To assess the feasibility of rapid, non-destructive metastatic tumor origin assessment.
Main Methods:
- Development of Raman consensus estimation, integrating Raman spectroscopic fingerprints with consensus sampling.
- Application of the framework to a proof-of-concept cohort of clinically confirmed colorectal liver metastases.
- Evaluation of spectral sampling requirements for clinical compatibility.
Main Results:
- The Raman consensus estimation framework successfully and accurately identified the primary origin of all tested colorectal liver metastases.
- Consensus voting demonstrated the feasibility of reduced spectral sampling, indicating potential for clinically relevant time constraints.
- The method is label-free and non-destructive.
Conclusions:
- Raman consensus estimation offers a rapid, non-destructive strategy for assessing metastatic tumor origin.
- This approach shows significant potential for improving the workup of cancers of unknown primary (CUP).
- The technique may aid in perioperative decision-making and the selection of origin-directed cancer therapies.
